Article Details
Retrieved on: 2021-01-19 05:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs has initiated coverage on Torrent Pharmaceuticals with a 'buy' rating and a target price of Rs 3,400. The brokerage firm believes that ...
Article found on: www.cnbctv18.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here